Virginia 2024 - Prostate Cancer Facts & Statistics

Download virginia's 2024 Prostate Cancer Facts & Statistics Sheet

Incidence Rates

• Given 100,000 Virginia men, 102.1 will be diagnosed with prostate cancer in their lifetime.
• 9,200 will be diagnosed this year.
• The state is ranked #37 in the country for prostate cancer incidences.

Mortality Rates

• 19.9 in every 100,000 men will die from prostate cancer in Virginia.
• 970 men in the state, this year alone.
• The state is ranked #19 in the country for prostate cancer deaths.

CDMRP Grants in Virginia

Year Introduced: 1997

Total Grants to Date: 56

Total Grand Awards Through FY 2022:** $21.4M 

Grant Recipient	Year	Amount
University of Virginia	2021	$1,128,336
Eastern Virginia Medical School	2017	$900,000
Virginia Commonwealth University	2017 2010 2004	$775,000  $606,723  $763,655

* Congressionally Directed Medical Research Programs 
**PCRP (Prostate Cancer Research Program) data for FY 2023 has not yet been posted

CDC’s National Comprehensive Cancer Control Program (NCCCP) Funding in Virginia

• Goal: Virginians are diagnosed with cancer at its earliest (local), most curable stage.
• Objective: Increase the dissemination of public information of age-appropriate, evidence-based, comprehensive cancer screening guidelines and resources and encourage an increase in educational activities in the Virginia health districts with the highest mortality rates. 
• Strategy: Collaborate with and engage businesses and other community partners such as professional groups, hospitals, and community-based organizations in identifying evidenced-based strategies to enhance knowledge about screening guidelines (educational sessions, incentives, time off for screening exams, etc.). 
• Strategy: Increase awareness for the use of genetic screening based on the individual’s level of risk.  
• Strategy: Educate patients about how to talk effectively with providers through use of resources promoting early detection methods that are right for the individual. 
• Strategy: Partner with other Cancer Action Coalition of Virginia (CACV) action team members to promote early detection awareness.
• Objective: Increase cancer screening rates among Virginians by 10%.
• Strategy: Work with the health districts, businesses and other community partners in identifying evidenced-based strategies to increase screening rates.  
• Strategy: Advocate at the state level for improved access to evidenced-based programs for early detection. 
• Strategy: Increase the awareness of evidenced-based programs across the state that provide screenings. 
• Strategy: Encourage additional educational activities in the cities and counties of Virginia with the highest cancer incidence and mortality rates.
• Strategy: Increase educational efforts and identify barriers of access to screening services in health districts with the lowest screening rates. 
• Objective: Support Virginia health care providers in promoting age-appropriate, evidence-based screening early detection guidelines. 
• Strategy: Identify effective training programs aimed at enhancing health care professionals’ knowledge and enhance available resources, including culturally appropriate communication tools. 
• Strategy: Identify and promote promising health system practices that improve early detection screening rates. 
• Strategy: Disseminate information on evidenced-based cancer screening guidelines to health care professionals (e.g., family physicians, OB-GYNs, other physicians, internists, nurse practitioners) performing or recommending cancer screening to their patients. PSA in the last two years - Baseline: 54.6%; Target: 60%.

Legislative Action

ZERO is proud to support HB 477, introduced by Delegate Terry Austing, which will eliminate cost-sharing for prostate cancer screening for high-risk men

ZERO is proud to support S791, introduced by NJ Sen. Troy Singleton to eliminate cost-sharing for prostate cancer screening for high-risk men.